
Bio Imaging Technologies Market Report 2026
Global Outlook – By Technology (Confocal Microscopy, Super-Resolution Microscopy, Electron Microscopy, Multiphoton Microscopy), By Sample Type (Live Cells, Fixed Cells, Tissues, Three-Dimensional (3D) Samples), By Contrast Agents (Ultrasound Contrast Agents, Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents, Nuclear Medicine Contrast Agents, Optical Contrast Agents), By Application (Oncology, Cardiology, Neurology, Orthopedics, Other Applications), By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Bio Imaging Technologies Market Overview
• Bio Imaging Technologies market size has reached to $7.14 billion in 2025 • Expected to grow to $11 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Increasing Demand For Diagnostic Procedures Fueling The Growth Of The Market Due To Rising Burden Of Chronic Diseases • Market Trend: New Advancements Enable High Speed Low Phototoxicity 3D Imaging • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Bio Imaging Technologies Market?
Bio imaging technologies refer to a broad range of techniques used to visualize and analyse biological structures and processes within living organisms or biological samples. These technologies are vital in both research and medicine, allowing scientists and clinicians to observe biological activity in real time or at specific stages without invasive procedures. The main types of bio imaging technologies are confocal microscopy, super-resolution microscopy, electron microscopy, and multiphoton microscopy. Confocal microscopy refers to an advanced optical imaging technique that uses point illumination and a spatial pinhole to eliminate out-of-focus light, thereby producing high-resolution and high-contrast images of thick specimens. These technologies can analyze various sample types, such as live cells, fixed cells, tissues, and three-dimensional (3D) samples, using a range of contrast agents including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, and optical contrast agents. They are applied in fields such as oncology, cardiology, neurology, orthopedics, and other medical areas, and their primary end users are hospitals, diagnostic imaging centers, research institutes, and other relevant organizations.
What Is The Bio Imaging Technologies Market Size and Share 2026?
The bio imaging technologies market size has grown strongly in recent years. It will grow from $7.14 billion in 2025 to $7.8 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growth in biomedical research funding, expansion of clinical diagnostic imaging usage, rising prevalence of chronic diseases, adoption of advanced microscopy technologies, increased demand for early disease detection.What Is The Bio Imaging Technologies Market Growth Forecast?
The bio imaging technologies market size is expected to see strong growth in the next few years. It will grow to $11 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to expansion of precision medicine adoption, rising demand for molecular imaging tools, growth in AI driven diagnostic platforms, increasing investment in healthcare infrastructure, integration of advanced imaging analytics. Major trends in the forecast period include high resolution imaging system development, AI assisted image analysis integration, non invasive diagnostic imaging expansion, real time cellular imaging tools, advanced contrast agent innovation.Global Bio Imaging Technologies Market Segmentation
1) By Technology: Confocal Microscopy, Super-Resolution Microscopy, Electron Microscopy, Multiphoton Microscopy 2) By Sample Type: Live Cells, Fixed Cells, Tissues, Three-Dimensional (3D) Samples 3) By Contrast Agents: Ultrasound Contrast Agents, Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents, Nuclear Medicine Contrast Agents, Optical Contrast Agents 4) By Application: Oncology, Cardiology, Neurology, Orthopedics, Other Applications 5) By End-User: Hospitals, Diagnostic Imaging Centers, Research Institutes, Other End Users Subsegments: 1) By Confocal Microscopy: Laser Scanning Confocal Microscopy, Spinning Disk Confocal Microscopy, Programmable Array Microscopy 2) By Super-Resolution Microscopy: Stimulated Emission Depletion Microscopy, Structured Illumination Microscopy, Single Molecule Localization Microscopy 3) By Electron Microscopy: Transmission Electron Microscopy, Scanning Electron Microscopy, Cryo Electron Microscopy 4) By Multiphoton Microscopy: Two Photon Excitation Microscopy, Three Photon Excitation Microscopy, Multiharmonic Generation MicroscopyWhat Is The Driver Of The Bio Imaging Technologies Market?
The increasing demand for diagnostic procedures is expected to propel the growth of the bio imaging technologies market going forward. Diagnostic procedures refer to medical tests and techniques, such as imaging scans, biopsies, and laboratory analyses, that are used to detect, monitor, and evaluate diseases or medical conditions. The rising diagnostic procedures are due to the growing burden of chronic diseases, which require frequent and accurate testing for early detection, continuous monitoring, and effective management of patient health outcomes. Bio imaging technologies enhance diagnostic procedures by providing detailed visualization of internal organs and tissues, enabling accurate disease detection and monitoring. They support early diagnosis through advanced imaging methods, improving treatment planning and overall patient outcomes. For instance, in November 2023, according to the National Health Service, a UK-based government department, the number of imaging tests performed in England reached 45.0 million in the year to March 2023, an increase of 2.2% from 44.0 million in 2022. Therefore, the increasing demand for diagnostic procedures is driving the growth of the bio imaging technologies industry.Key Players In The Global Bio Imaging Technologies Market
Major companies operating in the bio imaging technologies market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Konica Minolta Inc., Agilent Technologies Inc., Keyence Corporation, Olympus Corporation, Nikon Corporation, Hologic Inc., Shimadzu Corporation, Bruker Corporation, Hamamatsu Photonics K.K., Carestream Health Inc., Esaote S.p.A., Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Applied Spectral Imaging, MARS Bioimaging LimitedGlobal Bio Imaging Technologies Market Trends and Insights
Major companies operating in the bio imaging technologies market are focusing on developing innovative technologies, such as spinning disk confocal technology, which allows for high-resolution imaging of live cells with minimal phototoxicity. Spinning disk confocal technology is a fluorescence microscopy method that uses a rotating disk with multiple pinholes to scan samples with laser light, helping researchers capture fast, high-resolution, low-phototoxicity 3D images of live cells and tissues in real time. For instance, in May 2025, Evident Co. Ltd., a Japan-based laboratory equipment manufacturer, launched the IXplore IX85 SpinXL and IXplore IX85 SpinSR spinning disk confocal microscopes to advance live-cell imaging. The SpinXL, powered by CrestOptics X-light technology, offers a wide 26.5 mm field number, high-speed imaging up to 498 fps, and gentle NIR-based imaging for large-area cellular studies. The SpinSR, equipped with Yokogawa CSU-W1 technology, delivers super-resolution imaging down to 120 nm with Trusight SR algorithms for fast, detailed 3D analysis. Both systems support 3D volumetric reconstruction with Evident’s silicone gel pad objective, enabling researchers to capture deeper and more precise biological insights.What Are Latest Mergers And Acquisitions In The Bio Imaging Technologies Market?
In January 2025, Quanterix Corporation, a US-based biotechnology company, acquired Akoya Biosciences Inc. for an undisclosed amount. With this acquisition, Quanterix aims to create the first fully integrated solution for blood-and tissue-based protein biomarker detection, broaden its reach in neurology, oncology, and immunology, boost sales through cross-selling, and drive profitability through cost and operational efficiencies. Akoya Biosciences Inc. is a US-based biotechnology company that specializes in providing bio imaging technologies.Regional Insights
North America was the largest region in the bio imaging technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Bio Imaging Technologies Market?
The bio imaging technologies market consists of revenues earned by entities by providing services such as contract imaging for clinical trials and drug development, centralized image analysis and core lab services, education and training programs, digital image processing, and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The bio imaging technologies market also includes sales of image analysis software, AI-powered platforms, whole-slide imaging systems, fluorescent dyes, contrast agents, radiopharmaceuticals, probe-based endomicroscopy tools, and hyperspectral imaging microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Bio Imaging Technologies Market Report 2026?
The bio imaging technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bio imaging technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bio Imaging Technologies Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.8 billion |
| Revenue Forecast In 2035 | $11 billion |
| Growth Rate | CAGR of 9.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Technology, Sample Type, Contrast Agents, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Konica Minolta Inc., Agilent Technologies Inc., Keyence Corporation, Olympus Corporation, Nikon Corporation, Hologic Inc., Shimadzu Corporation, Bruker Corporation, Hamamatsu Photonics K.K., Carestream Health Inc., Esaote S.p.A., Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Applied Spectral Imaging, MARS Bioimaging Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
